nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—skin cancer—head and neck cancer	0.894	1	CtDrD
Imiquimod—Cutaneous lupus erythematosus—Docetaxel—head and neck cancer	0.00387	0.0492	CcSEcCtD
Imiquimod—Papule—Hydroxyurea—head and neck cancer	0.00322	0.0409	CcSEcCtD
Imiquimod—Application site burn—Fluorouracil—head and neck cancer	0.00241	0.0307	CcSEcCtD
Imiquimod—Ischaemia—Vinblastine—head and neck cancer	0.00211	0.0268	CcSEcCtD
Imiquimod—Scab—Fluorouracil—head and neck cancer	0.00159	0.0202	CcSEcCtD
Imiquimod—CYP1A2—Arylamine metabolism—NAT2—head and neck cancer	0.00134	0.05	CbGpPWpGaD
Imiquimod—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00118	0.015	CcSEcCtD
Imiquimod—Platelet count decreased—Hydroxyurea—head and neck cancer	0.00118	0.015	CcSEcCtD
Imiquimod—Application site pain—Fluorouracil—head and neck cancer	0.00115	0.0146	CcSEcCtD
Imiquimod—Application site reaction—Fluorouracil—head and neck cancer	0.00108	0.0137	CcSEcCtD
Imiquimod—Cardiomyopathy—Fluorouracil—head and neck cancer	0.000988	0.0126	CcSEcCtD
Imiquimod—Local reaction—Fluorouracil—head and neck cancer	0.000913	0.0116	CcSEcCtD
Imiquimod—Skin ulcer—Hydroxyurea—head and neck cancer	0.000902	0.0115	CcSEcCtD
Imiquimod—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00085	0.0108	CcSEcCtD
Imiquimod—Tenderness—Hydroxyurea—head and neck cancer	0.000805	0.0102	CcSEcCtD
Imiquimod—Bone pain—Vinblastine—head and neck cancer	0.000804	0.0102	CcSEcCtD
Imiquimod—Ulcer—Hydroxyurea—head and neck cancer	0.000743	0.00944	CcSEcCtD
Imiquimod—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.000743	0.00944	CcSEcCtD
Imiquimod—Skin exfoliation—Hydroxyurea—head and neck cancer	0.000671	0.00852	CcSEcCtD
Imiquimod—Tingling sensation—Fluorouracil—head and neck cancer	0.000629	0.00799	CcSEcCtD
Imiquimod—Pulmonary oedema—Hydroxyurea—head and neck cancer	0.000625	0.00794	CcSEcCtD
Imiquimod—Stinging—Fluorouracil—head and neck cancer	0.000624	0.00793	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—CASP8—head and neck cancer	0.000623	0.0232	CbGpPWpGaD
Imiquimod—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.000614	0.0078	CcSEcCtD
Imiquimod—CYP1A2—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000587	0.0218	CbGpPWpGaD
Imiquimod—Tenderness—Fluorouracil—head and neck cancer	0.00058	0.00736	CcSEcCtD
Imiquimod—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000571	0.00725	CcSEcCtD
Imiquimod—Supraventricular tachycardia—Docetaxel—head and neck cancer	0.000557	0.00708	CcSEcCtD
Imiquimod—Herpes simplex—Fluorouracil—head and neck cancer	0.000549	0.00697	CcSEcCtD
Imiquimod—Cyst—Docetaxel—head and neck cancer	0.000546	0.00694	CcSEcCtD
Imiquimod—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.000541	0.00687	CcSEcCtD
Imiquimod—Laryngeal pain—Docetaxel—head and neck cancer	0.000535	0.0068	CcSEcCtD
Imiquimod—Ulcer—Fluorouracil—head and neck cancer	0.000535	0.00679	CcSEcCtD
Imiquimod—Haemoglobin decreased—Docetaxel—head and neck cancer	0.00053	0.00674	CcSEcCtD
Imiquimod—Inflammation—Fluorouracil—head and neck cancer	0.000521	0.00662	CcSEcCtD
Imiquimod—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—head and neck cancer	0.0005	0.0186	CbGpPWpGaD
Imiquimod—Face oedema—Hydroxyurea—head and neck cancer	0.000492	0.00625	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CASP8—head and neck cancer	0.000487	0.0181	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—CASP8—head and neck cancer	0.000481	0.0179	CbGpPWpGaD
Imiquimod—Rash erythematous—Docetaxel—head and neck cancer	0.000477	0.00605	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CASP8—head and neck cancer	0.000472	0.0176	CbGpPWpGaD
Imiquimod—Otitis media—Docetaxel—head and neck cancer	0.000469	0.00596	CcSEcCtD
Imiquimod—Breast disorder—Hydroxyurea—head and neck cancer	0.000461	0.00585	CcSEcCtD
Imiquimod—Pancytopenia—Vinblastine—head and neck cancer	0.000459	0.00583	CcSEcCtD
Imiquimod—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—head and neck cancer	0.000455	0.0169	CbGpPWpGaD
Imiquimod—CYP3A4—Aflatoxin B1 metabolism—GSTM1—head and neck cancer	0.000453	0.0169	CbGpPWpGaD
Imiquimod—Rigors—Docetaxel—head and neck cancer	0.000447	0.00568	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK3—head and neck cancer	0.000434	0.0162	CbGpPWpGaD
Imiquimod—Depression—Vinblastine—head and neck cancer	0.00043	0.00546	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—STAT6—head and neck cancer	0.000429	0.016	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—MAPK3—head and neck cancer	0.000426	0.0159	CbGpPWpGaD
Imiquimod—Acute coronary syndrome—Vinblastine—head and neck cancer	0.000425	0.0054	CcSEcCtD
Imiquimod—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000422	0.00537	CcSEcCtD
Imiquimod—Myocardial infarction—Vinblastine—head and neck cancer	0.000422	0.00537	CcSEcCtD
Imiquimod—Pancytopenia—Hydroxyurea—head and neck cancer	0.000419	0.00532	CcSEcCtD
Imiquimod—Swelling—Fluorouracil—head and neck cancer	0.000416	0.00529	CcSEcCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—head and neck cancer	0.000413	0.0154	CbGpPWpGaD
Imiquimod—Dysuria—Hydroxyurea—head and neck cancer	0.000412	0.00524	CcSEcCtD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—head and neck cancer	0.000411	0.0153	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—MAPK1—head and neck cancer	0.000405	0.0151	CbGpPWpGaD
Imiquimod—Infestation—Hydroxyurea—head and neck cancer	0.000393	0.00499	CcSEcCtD
Imiquimod—Infestation NOS—Hydroxyurea—head and neck cancer	0.000393	0.00499	CcSEcCtD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—head and neck cancer	0.000391	0.0146	CbGpPWpGaD
Imiquimod—Haemoglobin—Vinblastine—head and neck cancer	0.000389	0.00494	CcSEcCtD
Imiquimod—Haemorrhage—Vinblastine—head and neck cancer	0.000387	0.00491	CcSEcCtD
Imiquimod—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000385	0.00489	CcSEcCtD
Imiquimod—Pharyngitis—Vinblastine—head and neck cancer	0.000384	0.00488	CcSEcCtD
Imiquimod—Bone pain—Docetaxel—head and neck cancer	0.000381	0.00484	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—MAPK3—head and neck cancer	0.000379	0.0141	CbGpPWpGaD
Imiquimod—Inflammation—Docetaxel—head and neck cancer	0.000376	0.00478	CcSEcCtD
Imiquimod—Cardiac failure—Fluorouracil—head and neck cancer	0.000376	0.00478	CcSEcCtD
Imiquimod—Lethargy—Fluorouracil—head and neck cancer	0.000375	0.00476	CcSEcCtD
Imiquimod—Hepatobiliary disease—Hydroxyurea—head and neck cancer	0.000372	0.00472	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CASP8—head and neck cancer	0.000369	0.0137	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—CASP8—head and neck cancer	0.000365	0.0136	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—MAPK1—head and neck cancer	0.00036	0.0134	CbGpPWpGaD
Imiquimod—Haemoglobin—Hydroxyurea—head and neck cancer	0.000355	0.0045	CcSEcCtD
Imiquimod—Influenza like illness—Docetaxel—head and neck cancer	0.000354	0.0045	CcSEcCtD
Imiquimod—Haemorrhage—Hydroxyurea—head and neck cancer	0.000353	0.00448	CcSEcCtD
Imiquimod—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—head and neck cancer	0.000351	0.0131	CbGpPWpGaD
Imiquimod—Irritability—Fluorouracil—head and neck cancer	0.00035	0.00445	CcSEcCtD
Imiquimod—Skin exfoliation—Docetaxel—head and neck cancer	0.000348	0.00443	CcSEcCtD
Imiquimod—Alopecia—Vinblastine—head and neck cancer	0.000342	0.00434	CcSEcCtD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—CYP1A1—head and neck cancer	0.000339	0.0126	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK3—head and neck cancer	0.000329	0.0122	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—STAT6—head and neck cancer	0.000325	0.0121	CbGpPWpGaD
Imiquimod—Pulmonary oedema—Docetaxel—head and neck cancer	0.000325	0.00413	CcSEcCtD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—MAPK3—head and neck cancer	0.000323	0.012	CbGpPWpGaD
Imiquimod—Angiopathy—Hydroxyurea—head and neck cancer	0.00032	0.00407	CcSEcCtD
Imiquimod—Chills—Hydroxyurea—head and neck cancer	0.000317	0.00402	CcSEcCtD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—head and neck cancer	0.000313	0.0117	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—PIK3CA—head and neck cancer	0.000313	0.0116	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Vinblastine—head and neck cancer	0.000312	0.00397	CcSEcCtD
Imiquimod—Alopecia—Hydroxyurea—head and neck cancer	0.000312	0.00396	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK3—head and neck cancer	0.000312	0.0116	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—MAPK1—head and neck cancer	0.000307	0.0114	CbGpPWpGaD
Imiquimod—Erythema—Hydroxyurea—head and neck cancer	0.000307	0.0039	CcSEcCtD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000307	0.0114	CbGpPWpGaD
Imiquimod—Malaise—Vinblastine—head and neck cancer	0.000304	0.00386	CcSEcCtD
Imiquimod—Pancytopenia—Fluorouracil—head and neck cancer	0.000301	0.00383	CcSEcCtD
Imiquimod—Swelling—Docetaxel—head and neck cancer	0.0003	0.00382	CcSEcCtD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—head and neck cancer	0.000296	0.011	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK3—head and neck cancer	0.000296	0.011	CbGpPWpGaD
Imiquimod—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000295	0.00375	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK3—head and neck cancer	0.000292	0.0109	CbGpPWpGaD
Imiquimod—Convulsion—Vinblastine—head and neck cancer	0.000292	0.00371	CcSEcCtD
Imiquimod—Hypertension—Vinblastine—head and neck cancer	0.000291	0.00369	CcSEcCtD
Imiquimod—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00029	0.00368	CcSEcCtD
Imiquimod—CYP1A2—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000287	0.0107	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK3—head and neck cancer	0.000287	0.0107	CbGpPWpGaD
Imiquimod—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000285	0.00362	CcSEcCtD
Imiquimod—Discomfort—Vinblastine—head and neck cancer	0.000283	0.0036	CcSEcCtD
Imiquimod—Infestation—Fluorouracil—head and neck cancer	0.000283	0.00359	CcSEcCtD
Imiquimod—Infestation NOS—Fluorouracil—head and neck cancer	0.000283	0.00359	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK1—head and neck cancer	0.000281	0.0105	CbGpPWpGaD
Imiquimod—Atrial fibrillation—Docetaxel—head and neck cancer	0.00028	0.00355	CcSEcCtD
Imiquimod—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000279	0.00354	CcSEcCtD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK1—head and neck cancer	0.000278	0.0104	CbGpPWpGaD
Imiquimod—Myocardial infarction—Fluorouracil—head and neck cancer	0.000277	0.00352	CcSEcCtD
Imiquimod—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000277	0.00352	CcSEcCtD
Imiquimod—Malaise—Hydroxyurea—head and neck cancer	0.000277	0.00352	CcSEcCtD
Imiquimod—CYP1A2—Estrogen metabolism—GSTM1—head and neck cancer	0.000276	0.0103	CbGpPWpGaD
Imiquimod—Conjunctivitis—Fluorouracil—head and neck cancer	0.000275	0.00349	CcSEcCtD
Imiquimod—Urinary tract infection—Fluorouracil—head and neck cancer	0.000275	0.00349	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK1—head and neck cancer	0.000273	0.0102	CbGpPWpGaD
Imiquimod—Cardiac failure—Docetaxel—head and neck cancer	0.000271	0.00345	CcSEcCtD
Imiquimod—Lethargy—Docetaxel—head and neck cancer	0.00027	0.00343	CcSEcCtD
Imiquimod—Convulsion—Hydroxyurea—head and neck cancer	0.000266	0.00338	CcSEcCtD
Imiquimod—Sinusitis—Fluorouracil—head and neck cancer	0.000265	0.00337	CcSEcCtD
Imiquimod—Pain in extremity—Docetaxel—head and neck cancer	0.000265	0.00337	CcSEcCtD
Imiquimod—Anorexia—Vinblastine—head and neck cancer	0.000262	0.00333	CcSEcCtD
Imiquimod—CYP1A2—Estrogen metabolism—CYP1A1—head and neck cancer	0.000261	0.00973	CbGpPWpGaD
Imiquimod—Migraine—Docetaxel—head and neck cancer	0.000261	0.00331	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.00026	0.0033	CcSEcCtD
Imiquimod—Discomfort—Hydroxyurea—head and neck cancer	0.000258	0.00328	CcSEcCtD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	0.000255	0.00951	CbGpPWpGaD
Imiquimod—Haemoglobin—Fluorouracil—head and neck cancer	0.000255	0.00324	CcSEcCtD
Imiquimod—Rhinitis—Fluorouracil—head and neck cancer	0.000255	0.00323	CcSEcCtD
Imiquimod—Haemorrhage—Fluorouracil—head and neck cancer	0.000254	0.00323	CcSEcCtD
Imiquimod—Pharyngitis—Fluorouracil—head and neck cancer	0.000252	0.0032	CcSEcCtD
Imiquimod—Oedema—Hydroxyurea—head and neck cancer	0.000251	0.00318	CcSEcCtD
Imiquimod—TLR8—Immune System—STAT6—head and neck cancer	0.00025	0.0093	CbGpPWpGaD
Imiquimod—Infection—Hydroxyurea—head and neck cancer	0.000249	0.00316	CcSEcCtD
Imiquimod—Paraesthesia—Vinblastine—head and neck cancer	0.000247	0.00314	CcSEcCtD
Imiquimod—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000246	0.00312	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.000244	0.00909	CbGpPWpGaD
Imiquimod—Skin disorder—Hydroxyurea—head and neck cancer	0.000243	0.00309	CcSEcCtD
Imiquimod—CYP1A2—Xenobiotics—CYP1A1—head and neck cancer	0.00024	0.00894	CbGpPWpGaD
Imiquimod—Breast disorder—Docetaxel—head and neck cancer	0.000239	0.00304	CcSEcCtD
Imiquimod—Anorexia—Hydroxyurea—head and neck cancer	0.000239	0.00304	CcSEcCtD
Imiquimod—Decreased appetite—Vinblastine—head and neck cancer	0.000239	0.00304	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—PIK3CA—head and neck cancer	0.000237	0.00882	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—head and neck cancer	0.000237	0.00882	CbGpPWpGaD
Imiquimod—Pain—Vinblastine—head and neck cancer	0.000235	0.00299	CcSEcCtD
Imiquimod—CYP1A2—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000231	0.0086	CbGpPWpGaD
Imiquimod—Arrhythmia—Fluorouracil—head and neck cancer	0.000227	0.00288	CcSEcCtD
Imiquimod—Feeling abnormal—Vinblastine—head and neck cancer	0.000226	0.00288	CcSEcCtD
Imiquimod—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000225	0.00286	CcSEcCtD
Imiquimod—Alopecia—Fluorouracil—head and neck cancer	0.000224	0.00285	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK3—head and neck cancer	0.000224	0.00834	CbGpPWpGaD
Imiquimod—Dyspnoea—Hydroxyurea—head and neck cancer	0.000223	0.00284	CcSEcCtD
Imiquimod—Somnolence—Hydroxyurea—head and neck cancer	0.000223	0.00283	CcSEcCtD
Imiquimod—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—head and neck cancer	0.000222	0.00825	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK3—head and neck cancer	0.000221	0.00824	CbGpPWpGaD
Imiquimod—Erythema—Fluorouracil—head and neck cancer	0.000221	0.00281	CcSEcCtD
Imiquimod—Dyspepsia—Hydroxyurea—head and neck cancer	0.000221	0.0028	CcSEcCtD
Imiquimod—Decreased appetite—Hydroxyurea—head and neck cancer	0.000218	0.00277	CcSEcCtD
Imiquimod—Pancytopenia—Docetaxel—head and neck cancer	0.000217	0.00276	CcSEcCtD
Imiquimod—Abdominal pain—Vinblastine—head and neck cancer	0.000217	0.00276	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000216	0.00275	CcSEcCtD
Imiquimod—Fatigue—Hydroxyurea—head and neck cancer	0.000216	0.00275	CcSEcCtD
Imiquimod—Pain—Hydroxyurea—head and neck cancer	0.000214	0.00272	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK1—head and neck cancer	0.000213	0.00794	CbGpPWpGaD
Imiquimod—CYP3A4—Estrogen metabolism—GSTM1—head and neck cancer	0.000213	0.00792	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK1—head and neck cancer	0.000211	0.00784	CbGpPWpGaD
Imiquimod—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000207	0.00262	CcSEcCtD
Imiquimod—Infestation NOS—Docetaxel—head and neck cancer	0.000204	0.00259	CcSEcCtD
Imiquimod—Infestation—Docetaxel—head and neck cancer	0.000204	0.00259	CcSEcCtD
Imiquimod—Hypersensitivity—Vinblastine—head and neck cancer	0.000202	0.00257	CcSEcCtD
Imiquimod—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000202	0.00257	CcSEcCtD
Imiquimod—CYP3A4—Estrogen metabolism—CYP1A1—head and neck cancer	0.000202	0.00751	CbGpPWpGaD
Imiquimod—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000201	0.00256	CcSEcCtD
Imiquimod—Myocardial infarction—Docetaxel—head and neck cancer	0.0002	0.00254	CcSEcCtD
Imiquimod—Neuropathy peripheral—Docetaxel—head and neck cancer	0.0002	0.00254	CcSEcCtD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000199	0.00742	CbGpPWpGaD
Imiquimod—Conjunctivitis—Docetaxel—head and neck cancer	0.000198	0.00252	CcSEcCtD
Imiquimod—Body temperature increased—Hydroxyurea—head and neck cancer	0.000198	0.00252	CcSEcCtD
Imiquimod—Asthenia—Vinblastine—head and neck cancer	0.000197	0.00251	CcSEcCtD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—AKT1—head and neck cancer	0.000194	0.00721	CbGpPWpGaD
Imiquimod—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000193	0.00245	CcSEcCtD
Imiquimod—Convulsion—Fluorouracil—head and neck cancer	0.000192	0.00243	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—BCL2L1—head and neck cancer	0.000191	0.0071	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT6—head and neck cancer	0.000189	0.00705	CbGpPWpGaD
Imiquimod—Myalgia—Fluorouracil—head and neck cancer	0.000188	0.00239	CcSEcCtD
Imiquimod—Chest pain—Fluorouracil—head and neck cancer	0.000188	0.00239	CcSEcCtD
Imiquimod—Diarrhoea—Vinblastine—head and neck cancer	0.000188	0.00239	CcSEcCtD
Imiquimod—Discomfort—Fluorouracil—head and neck cancer	0.000186	0.00236	CcSEcCtD
Imiquimod—CYP3A4—Xenobiotics—CYP1A1—head and neck cancer	0.000185	0.0069	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—PIK3CA—head and neck cancer	0.000185	0.00689	CbGpPWpGaD
Imiquimod—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000185	0.00235	CcSEcCtD
Imiquimod—Haemoglobin—Docetaxel—head and neck cancer	0.000184	0.00234	CcSEcCtD
Imiquimod—Rhinitis—Docetaxel—head and neck cancer	0.000184	0.00233	CcSEcCtD
Imiquimod—Haemorrhage—Docetaxel—head and neck cancer	0.000183	0.00233	CcSEcCtD
Imiquimod—Pharyngitis—Docetaxel—head and neck cancer	0.000182	0.00231	CcSEcCtD
Imiquimod—Dizziness—Vinblastine—head and neck cancer	0.000182	0.00231	CcSEcCtD
Imiquimod—Urinary tract disorder—Docetaxel—head and neck cancer	0.000181	0.0023	CcSEcCtD
Imiquimod—Oedema—Fluorouracil—head and neck cancer	0.00018	0.00229	CcSEcCtD
Imiquimod—Connective tissue disorder—Docetaxel—head and neck cancer	0.00018	0.00229	CcSEcCtD
Imiquimod—Asthenia—Hydroxyurea—head and neck cancer	0.00018	0.00228	CcSEcCtD
Imiquimod—Urethral disorder—Docetaxel—head and neck cancer	0.00018	0.00228	CcSEcCtD
Imiquimod—Infection—Fluorouracil—head and neck cancer	0.000179	0.00228	CcSEcCtD
Imiquimod—CYP1A2—Melatonin metabolism and effects—CYP1A1—head and neck cancer	0.000178	0.00664	CbGpPWpGaD
Imiquimod—CYP3A4—Tamoxifen metabolism—CYP1A1—head and neck cancer	0.000178	0.00664	CbGpPWpGaD
Imiquimod—Nervous system disorder—Fluorouracil—head and neck cancer	0.000177	0.00225	CcSEcCtD
Imiquimod—Visual impairment—Docetaxel—head and neck cancer	0.000177	0.00224	CcSEcCtD
Imiquimod—Tachycardia—Fluorouracil—head and neck cancer	0.000176	0.00224	CcSEcCtD
Imiquimod—Vomiting—Vinblastine—head and neck cancer	0.000175	0.00222	CcSEcCtD
Imiquimod—Erythema multiforme—Docetaxel—head and neck cancer	0.000173	0.0022	CcSEcCtD
Imiquimod—Headache—Vinblastine—head and neck cancer	0.000172	0.00219	CcSEcCtD
Imiquimod—Anorexia—Fluorouracil—head and neck cancer	0.000172	0.00218	CcSEcCtD
Imiquimod—Diarrhoea—Hydroxyurea—head and neck cancer	0.000171	0.00218	CcSEcCtD
Imiquimod—Eye disorder—Docetaxel—head and neck cancer	0.000171	0.00218	CcSEcCtD
Imiquimod—Flushing—Docetaxel—head and neck cancer	0.00017	0.00216	CcSEcCtD
Imiquimod—Angiopathy—Docetaxel—head and neck cancer	0.000166	0.00211	CcSEcCtD
Imiquimod—Dizziness—Hydroxyurea—head and neck cancer	0.000166	0.00211	CcSEcCtD
Imiquimod—Immune system disorder—Docetaxel—head and neck cancer	0.000166	0.0021	CcSEcCtD
Imiquimod—Mediastinal disorder—Docetaxel—head and neck cancer	0.000165	0.0021	CcSEcCtD
Imiquimod—Chills—Docetaxel—head and neck cancer	0.000164	0.00209	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000164	0.00209	CcSEcCtD
Imiquimod—Arrhythmia—Docetaxel—head and neck cancer	0.000164	0.00208	CcSEcCtD
Imiquimod—Nausea—Vinblastine—head and neck cancer	0.000163	0.00207	CcSEcCtD
Imiquimod—Insomnia—Fluorouracil—head and neck cancer	0.000163	0.00207	CcSEcCtD
Imiquimod—Paraesthesia—Fluorouracil—head and neck cancer	0.000162	0.00206	CcSEcCtD
Imiquimod—Alopecia—Docetaxel—head and neck cancer	0.000162	0.00206	CcSEcCtD
Imiquimod—Dyspnoea—Fluorouracil—head and neck cancer	0.000161	0.00204	CcSEcCtD
Imiquimod—Mental disorder—Docetaxel—head and neck cancer	0.000161	0.00204	CcSEcCtD
Imiquimod—Somnolence—Fluorouracil—head and neck cancer	0.00016	0.00204	CcSEcCtD
Imiquimod—Malnutrition—Docetaxel—head and neck cancer	0.00016	0.00203	CcSEcCtD
Imiquimod—Erythema—Docetaxel—head and neck cancer	0.00016	0.00203	CcSEcCtD
Imiquimod—Vomiting—Hydroxyurea—head and neck cancer	0.000159	0.00202	CcSEcCtD
Imiquimod—Dyspepsia—Fluorouracil—head and neck cancer	0.000159	0.00202	CcSEcCtD
Imiquimod—Rash—Hydroxyurea—head and neck cancer	0.000158	0.00201	CcSEcCtD
Imiquimod—Dermatitis—Hydroxyurea—head and neck cancer	0.000158	0.00201	CcSEcCtD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—head and neck cancer	0.000157	0.00585	CbGpPWpGaD
Imiquimod—Headache—Hydroxyurea—head and neck cancer	0.000157	0.00199	CcSEcCtD
Imiquimod—Decreased appetite—Fluorouracil—head and neck cancer	0.000157	0.00199	CcSEcCtD
Imiquimod—CYP1A2—Phase II conjugation—NAT2—head and neck cancer	0.000157	0.00584	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CASP8—head and neck cancer	0.000156	0.0058	CbGpPWpGaD
Imiquimod—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000156	0.00198	CcSEcCtD
Imiquimod—Back pain—Docetaxel—head and neck cancer	0.000154	0.00196	CcSEcCtD
Imiquimod—Pain—Fluorouracil—head and neck cancer	0.000154	0.00196	CcSEcCtD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—AKT1—head and neck cancer	0.000151	0.00562	CbGpPWpGaD
Imiquimod—Nausea—Hydroxyurea—head and neck cancer	0.000149	0.00189	CcSEcCtD
Imiquimod—Feeling abnormal—Fluorouracil—head and neck cancer	0.000149	0.00189	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—BCL2L1—head and neck cancer	0.000144	0.00538	CbGpPWpGaD
Imiquimod—Urticaria—Fluorouracil—head and neck cancer	0.000143	0.00182	CcSEcCtD
Imiquimod—Syncope—Docetaxel—head and neck cancer	0.000143	0.00182	CcSEcCtD
Imiquimod—Body temperature increased—Fluorouracil—head and neck cancer	0.000143	0.00181	CcSEcCtD
Imiquimod—Palpitations—Docetaxel—head and neck cancer	0.000141	0.00179	CcSEcCtD
Imiquimod—Loss of consciousness—Docetaxel—head and neck cancer	0.00014	0.00178	CcSEcCtD
Imiquimod—Cough—Docetaxel—head and neck cancer	0.000139	0.00177	CcSEcCtD
Imiquimod—Convulsion—Docetaxel—head and neck cancer	0.000138	0.00176	CcSEcCtD
Imiquimod—Hypertension—Docetaxel—head and neck cancer	0.000138	0.00175	CcSEcCtD
Imiquimod—Arthralgia—Docetaxel—head and neck cancer	0.000136	0.00173	CcSEcCtD
Imiquimod—Myalgia—Docetaxel—head and neck cancer	0.000136	0.00173	CcSEcCtD
Imiquimod—Chest pain—Docetaxel—head and neck cancer	0.000136	0.00173	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000135	0.00171	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—BCL2—head and neck cancer	0.000134	0.00498	CbGpPWpGaD
Imiquimod—Hypersensitivity—Fluorouracil—head and neck cancer	0.000133	0.00169	CcSEcCtD
Imiquimod—Dry mouth—Docetaxel—head and neck cancer	0.000133	0.00169	CcSEcCtD
Imiquimod—Oedema—Docetaxel—head and neck cancer	0.00013	0.00165	CcSEcCtD
Imiquimod—Infection—Docetaxel—head and neck cancer	0.000129	0.00164	CcSEcCtD
Imiquimod—Shock—Docetaxel—head and neck cancer	0.000128	0.00163	CcSEcCtD
Imiquimod—Nervous system disorder—Docetaxel—head and neck cancer	0.000128	0.00162	CcSEcCtD
Imiquimod—Pruritus—Fluorouracil—head and neck cancer	0.000128	0.00162	CcSEcCtD
Imiquimod—Tachycardia—Docetaxel—head and neck cancer	0.000127	0.00161	CcSEcCtD
Imiquimod—Skin disorder—Docetaxel—head and neck cancer	0.000126	0.00161	CcSEcCtD
Imiquimod—Anorexia—Docetaxel—head and neck cancer	0.000124	0.00158	CcSEcCtD
Imiquimod—Diarrhoea—Fluorouracil—head and neck cancer	0.000123	0.00157	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000123	0.00459	CbGpPWpGaD
Imiquimod—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000123	0.00459	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000123	0.00459	CbGpPWpGaD
Imiquimod—Dizziness—Fluorouracil—head and neck cancer	0.000119	0.00152	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000119	0.00151	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CASP8—head and neck cancer	0.000118	0.0044	CbGpPWpGaD
Imiquimod—Insomnia—Docetaxel—head and neck cancer	0.000118	0.0015	CcSEcCtD
Imiquimod—Paraesthesia—Docetaxel—head and neck cancer	0.000117	0.00149	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000117	0.00434	CbGpPWpGaD
Imiquimod—Dyspnoea—Docetaxel—head and neck cancer	0.000116	0.00147	CcSEcCtD
Imiquimod—Somnolence—Docetaxel—head and neck cancer	0.000116	0.00147	CcSEcCtD
Imiquimod—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000115	0.0043	CbGpPWpGaD
Imiquimod—Vomiting—Fluorouracil—head and neck cancer	0.000115	0.00146	CcSEcCtD
Imiquimod—Dyspepsia—Docetaxel—head and neck cancer	0.000115	0.00146	CcSEcCtD
Imiquimod—Rash—Fluorouracil—head and neck cancer	0.000114	0.00145	CcSEcCtD
Imiquimod—Dermatitis—Fluorouracil—head and neck cancer	0.000114	0.00144	CcSEcCtD
Imiquimod—Decreased appetite—Docetaxel—head and neck cancer	0.000113	0.00144	CcSEcCtD
Imiquimod—Headache—Fluorouracil—head and neck cancer	0.000113	0.00144	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000112	0.00143	CcSEcCtD
Imiquimod—Fatigue—Docetaxel—head and neck cancer	0.000112	0.00143	CcSEcCtD
Imiquimod—Pain—Docetaxel—head and neck cancer	0.000111	0.00141	CcSEcCtD
Imiquimod—TLR8—Immune System—BCL2L1—head and neck cancer	0.000111	0.00413	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PTEN—head and neck cancer	0.000111	0.00412	CbGpPWpGaD
Imiquimod—Feeling abnormal—Docetaxel—head and neck cancer	0.000107	0.00136	CcSEcCtD
Imiquimod—Nausea—Fluorouracil—head and neck cancer	0.000107	0.00136	CcSEcCtD
Imiquimod—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000106	0.00135	CcSEcCtD
Imiquimod—Abdominal pain—Docetaxel—head and neck cancer	0.000103	0.00131	CcSEcCtD
Imiquimod—Body temperature increased—Docetaxel—head and neck cancer	0.000103	0.00131	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—BCL2—head and neck cancer	0.000101	0.00377	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.97e-05	0.00371	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.84e-05	0.00366	CbGpPWpGaD
Imiquimod—Hypersensitivity—Docetaxel—head and neck cancer	9.59e-05	0.00122	CcSEcCtD
Imiquimod—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	9.52e-05	0.00354	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MAPK3—head and neck cancer	9.46e-05	0.00352	CbGpPWpGaD
Imiquimod—Asthenia—Docetaxel—head and neck cancer	9.34e-05	0.00119	CcSEcCtD
Imiquimod—Pruritus—Docetaxel—head and neck cancer	9.21e-05	0.00117	CcSEcCtD
Imiquimod—CYP1A2—Biological oxidations—NAT2—head and neck cancer	9.17e-05	0.00341	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CASP8—head and neck cancer	9.08e-05	0.00338	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	9.04e-05	0.00337	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MAPK1—head and neck cancer	9.01e-05	0.00335	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—EGFR—head and neck cancer	9e-05	0.00335	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CDH1—head and neck cancer	8.97e-05	0.00334	CbGpPWpGaD
Imiquimod—Diarrhoea—Docetaxel—head and neck cancer	8.91e-05	0.00113	CcSEcCtD
Imiquimod—Dizziness—Docetaxel—head and neck cancer	8.61e-05	0.00109	CcSEcCtD
Imiquimod—TLR7—Immune System—BCL2L1—head and neck cancer	8.41e-05	0.00313	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PTEN—head and neck cancer	8.39e-05	0.00313	CbGpPWpGaD
Imiquimod—Vomiting—Docetaxel—head and neck cancer	8.28e-05	0.00105	CcSEcCtD
Imiquimod—Rash—Docetaxel—head and neck cancer	8.21e-05	0.00104	CcSEcCtD
Imiquimod—Dermatitis—Docetaxel—head and neck cancer	8.2e-05	0.00104	CcSEcCtD
Imiquimod—Headache—Docetaxel—head and neck cancer	8.16e-05	0.00104	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	8.08e-05	0.00301	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—PIK3CA—head and neck cancer	7.81e-05	0.00291	CbGpPWpGaD
Imiquimod—TLR8—Immune System—BCL2—head and neck cancer	7.79e-05	0.0029	CbGpPWpGaD
Imiquimod—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	7.74e-05	0.00288	CbGpPWpGaD
Imiquimod—Nausea—Docetaxel—head and neck cancer	7.73e-05	0.000983	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	7.7e-05	0.00287	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	7.59e-05	0.00283	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	7.33e-05	0.00273	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HRAS—head and neck cancer	7.23e-05	0.00269	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK3—head and neck cancer	7.17e-05	0.00267	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—NAT2—head and neck cancer	7.08e-05	0.00264	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	6.98e-05	0.0026	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CASP8—head and neck cancer	6.88e-05	0.00256	CbGpPWpGaD
Imiquimod—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	6.86e-05	0.00255	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2—head and neck cancer	6.86e-05	0.00255	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK1—head and neck cancer	6.82e-05	0.00254	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—EGFR—head and neck cancer	6.82e-05	0.00254	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	6.8e-05	0.00253	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CDH1—head and neck cancer	6.8e-05	0.00253	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PTEN—head and neck cancer	6.45e-05	0.0024	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—AKT1—head and neck cancer	6.38e-05	0.00238	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	6.24e-05	0.00232	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—PIK3CA—head and neck cancer	5.92e-05	0.00221	CbGpPWpGaD
Imiquimod—TLR7—Immune System—BCL2—head and neck cancer	5.9e-05	0.0022	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	5.78e-05	0.00215	CbGpPWpGaD
Imiquimod—TLR8—Immune System—STAT3—head and neck cancer	5.77e-05	0.00215	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK3—head and neck cancer	5.51e-05	0.00205	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HRAS—head and neck cancer	5.48e-05	0.00204	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MAPK1—head and neck cancer	5.25e-05	0.00195	CbGpPWpGaD
Imiquimod—TLR8—Immune System—EGFR—head and neck cancer	5.24e-05	0.00195	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	5.2e-05	0.00194	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	5.2e-05	0.00194	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	5.2e-05	0.00194	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—head and neck cancer	5.2e-05	0.00193	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTEN—head and neck cancer	4.89e-05	0.00182	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—AKT1—head and neck cancer	4.84e-05	0.0018	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PIK3CA—head and neck cancer	4.55e-05	0.00169	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	4.53e-05	0.00169	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	4.47e-05	0.00166	CbGpPWpGaD
Imiquimod—TLR7—Immune System—STAT3—head and neck cancer	4.37e-05	0.00163	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	4.29e-05	0.0016	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	4.23e-05	0.00158	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HRAS—head and neck cancer	4.21e-05	0.00157	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK3—head and neck cancer	4.18e-05	0.00156	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	4.17e-05	0.00155	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK1—head and neck cancer	3.98e-05	0.00148	CbGpPWpGaD
Imiquimod—TLR7—Immune System—EGFR—head and neck cancer	3.97e-05	0.00148	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—UROD—head and neck cancer	3.78e-05	0.00141	CbGpPWpGaD
Imiquimod—TLR8—Immune System—AKT1—head and neck cancer	3.72e-05	0.00138	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.5e-05	0.0013	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PIK3CA—head and neck cancer	3.45e-05	0.00128	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.45e-05	0.00128	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	3.31e-05	0.00123	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	3.27e-05	0.00122	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HRAS—head and neck cancer	3.19e-05	0.00119	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	2.93e-05	0.00109	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—UROD—head and neck cancer	2.91e-05	0.00109	CbGpPWpGaD
Imiquimod—TLR7—Immune System—AKT1—head and neck cancer	2.82e-05	0.00105	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.67e-05	0.00062	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.65e-05	0.000614	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—NAT2—head and neck cancer	1.57e-05	0.000584	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—DPYD—head and neck cancer	1.38e-05	0.000512	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—YAP1—head and neck cancer	1.31e-05	0.000486	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—NAT2—head and neck cancer	1.21e-05	0.000451	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—DPYD—head and neck cancer	1.06e-05	0.000395	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—YAP1—head and neck cancer	1.01e-05	0.000375	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.81e-06	0.000365	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.55e-06	0.000318	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—TYMS—head and neck cancer	7.84e-06	0.000292	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GSTM1—head and neck cancer	7.75e-06	0.000288	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPX1—head and neck cancer	7.42e-06	0.000276	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP1A1—head and neck cancer	7.34e-06	0.000273	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—TYMS—head and neck cancer	6.05e-06	0.000225	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.03e-06	0.000225	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GSTM1—head and neck cancer	5.98e-06	0.000223	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPX1—head and neck cancer	5.72e-06	0.000213	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP1A1—head and neck cancer	5.67e-06	0.000211	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTGS2—head and neck cancer	4.37e-06	0.000163	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PTEN—head and neck cancer	3.81e-06	0.000142	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTGS2—head and neck cancer	3.37e-06	0.000125	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PTEN—head and neck cancer	2.94e-06	0.000109	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—PIK3CA—head and neck cancer	2.69e-06	0.0001	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—AKT1—head and neck cancer	2.19e-06	8.17e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.07e-06	7.72e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—AKT1—head and neck cancer	1.69e-06	6.31e-05	CbGpPWpGaD
